Synergistic effects of multiple natural products in pancreatic cancer cells

Zhiwei Wang1, Sita Desmoulin, Sanjeev Banerjee

  • 1Department of Pathology, Karmanos Cancer Institute, Wayne State University, Detroit, Michigan, United States.

Life Sciences
|July 22, 2008
PubMed

Insights

Combining isoflavone and curcumin significantly inhibits pancreatic cancer (PC) cell growth and induces apoptosis. This combination therapy, potentially involving multiple natural products, offers a promising strategy for PC prevention and treatment.

Area of Science:

  • Oncology
  • Molecular Biology
  • Nutritional Science

Background:

  • Pancreatic cancer (PC) is a leading cause of cancer-related death in the US, necessitating novel prevention and treatment strategies.
  • Dietary agents like isoflavones (from soy) and curcumin (from turmeric) show potential in PC prevention and treatment.
  • Investigating combined effects of these natural compounds is crucial for developing effective therapies.

Purpose of the Study:

  • To evaluate the synergistic effect of isoflavone and curcumin on pancreatic cancer cell growth inhibition and apoptosis.
  • To elucidate the molecular mechanisms underlying the combined action of isoflavone and curcumin.
  • To assess the efficacy of combining multiple natural agents for pancreatic cancer treatment.

Main Methods:

  • In vitro studies on pancreatic cancer cells treated with isoflavone, curcumin, or their combination.
  • Analysis of cell growth inhibition and apoptosis induction.
  • Assessment of molecular targets including Notch-1 expression and NF-kappaB signaling pathway activity.

Main Results:

  • The combination of isoflavone and curcumin demonstrated significantly greater inhibition of PC cell growth and induction of apoptosis compared to individual agents.
  • Combined treatment led to decreased Notch-1 expression and reduced DNA binding activity of NF-kappaB and its target genes (Cyclin D1, Bcl-2, Bcl-xL).
  • A combination of four natural agents at lower concentrations proved highly effective.

Conclusions:

  • Combination therapy with isoflavone and curcumin exhibits superior efficacy in inhibiting pancreatic cancer cell growth and inducing apoptosis.
  • The synergistic effect is partly mediated by the inhibition of Notch-1 and NF-kappaB signaling pathways.
  • Dietary strategies incorporating multiple natural products may be more beneficial than single agents for pancreatic cancer prevention and treatment.

Related Concept Videos

Combined Effects of Drugs: Synergism01:27

Combined Effects of Drugs: Synergism

Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...